CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity
在小鼠非小细胞肺癌模型中，CCL21-DC原位疫苗接种可克服免疫治疗耐药性并产生全身性肿瘤特异性免疫。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-006896
Salehi-Rad, Ramin; Lim, Raymond J; Du, Yushen; Tran, Linh M; Li, Rui; Ong, Stephanie L; Ling Huang, Zi; Dumitras, Camelia; Zhang, Tianhao; Park, Stacy J; Crosson, William; Kahangi, Bitta; Abascal, Jensen; Seet, Christopher; Oh, Michael; Shabihkhani, Maryam; Paul, Manash; Krysan, Kostyantyn; Lisberg, Aaron E; Garon, Edward B; Liu, Bin; Dubinett, Steven M
肺癌
肿瘤
肿瘤免疫
CCL2
治疗耐药
细胞生物学
CCL21
免疫/内分泌
